Nouvelle déclaration d'incident
No de la demande: 2012-1440
Numéro de référence du titulaire d'homologation: PROSAR Case #: 1-29352284
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Canada Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW MEXICO
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 100-1066
Nom du produit: Demand CS
Liquide
Oui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Inconnu
Propriétaire de l'animal
Bird / Oiseau
African Grey Parrot
1
Homme
26
Inconnu
Cutanée
Respiratoire
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Oui
Inconnu
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
1-29352284- the reporter, an office manager of a veterinary clinic, reports potential exposure of a pet to an insecticide containing lambda-cyhalothrin. The reporter indicated a 26 year old male African grey Parrot had presented with the primary complaint of being off balance and refusing to eat. The product had been applied to the home where the animal is kept by commercial pest control operator the day prior to the onset of signs. The reporter was unable to describe a discreet exposure incident but assumed potential respiratory and/or dermal exposure. The reporter was unable to describe application or re-entry of the animal. The reporter was advised the active ingredient is largely unstudied in this species, but that provided label instructions were followed toxicity would not be anticipated. Birds are not considered particularly sensitive to the effects of pyrethrins and pyrethroids, but they are considered VERY sensitive to inhalation of aerosols. The reporter was advised on appropriate dermal decontamination and that supportive care should be instituted while the veterinarian attending the animal investigated other etiology. The caller was provided product literature for the veterinarians independent evaluation. The reporter or veterinarians were not available on follow up, but a clinic staff member was able to inform the registrant that the animal had died. No further detail was available. The signs and outcome are not consistent with the expectations of routine product use.
Mort